Anna Vulpetti has over 25 years of experience in drug discovery in Pharma, at Pharmacia & Upjohn, Pharmacia, Pfizer, and since 2006 at Novartis. She is an Associate Director in the Global Discovery Chemistry department at Novartis with experience from hit finding technologies to hit-to-lead and late-stage optimization. By working interdisciplinary across different disease areas, she impacted multiple pipeline projects through molecular designs, knowledge in medicinal chemistry and structural chemistry.
Anna Vulpetti has co-authored more than 80 peer-reviewed scientific papers and many patents.